부산대학교 도서관

Pavan Bachireddy; Elham Azizi; Cassandra Burdziak; Vinhkhang N. Nguyen; Christina S. Ennis; Katie Maurer; Cameron Y. Park; Zi-Ning Choo; Shuqiang Li; Satyen H. Gohil; Neil G. Ruthen; Zhongqi Ge; Derin B. Keskin; Nicoletta Cieri; Kenneth J. Livak; Haesook T. Kim; Donna S. Neuberg; Robert J. Soiffer; Jerome Ritz; Edwin P. Alyea; Dana Pe’er; Catherine J. Wu

Cell Reports, Vol 42, Iss 8, Pp 113011- (2023)

Bachireddy, Pavan; Azizi, Elham; Burdziak, Cassandra; Nguyen, Vinhkhang N.; Ennis, Christina S.; Maurer, Katie; Park, Cameron Y.; Choo, Zi-Ning; Li, Shuqiang; Gohil, Satyen H.; Ruthen, Neil G.; Ge, Zhongqi; Keskin, Derin B.; Cieri, Nicoletta; Livak, Kenneth J.; Kim, Haesook T.; Neuberg, Donna S.; Soiffer, Robert J.; Ritz, Jerome; Alyea, Edwin P.; Pe’er, Dana; Wu, Catherine J.

In Cell Reports 9 November 2021 37(6)

Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Lemvigh CK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.; Deng S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Dangle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ruthen N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Knisbacher BA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Broséus J; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France; Université de Lorraine, CHRU-Nancy, Service d'hématologie Biologique, Pôle Laboratoires, 54000 Nancy, France.; Hergalant S; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France.; Guièze R; CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France; EA 7453 (CHELTER), Université Clermont Auvergne, 63001 Clermont-Ferrand, France.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Zhang W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Johnson C; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Long JM; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA 02115, USA.; Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Werner L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Anandappa A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Purroy N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Gohil S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA.; Bachireddy P; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Shukla SA; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Huang T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Khoury JD; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.; Thakral B; Department of Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.; Dickinson M; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Tam C; Alfred Health, Melbourne, VIC, Australia; Monash University, Melbourne, VIC, Australia.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Getz G; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Feugier P; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France; Université de Lorraine, CHRU Nancy, service d'hématologie clinique, Nancy, France.; Kharchenko P; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02215, USA.; Wierda W; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; Olsen LR; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.; Jain N; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: Catherine_wu@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Bachireddy, Pavan; Azizi, Elham; Burdziak, Cassandra; Nguyen, Vinhkhang N.; Ennis, Christina S.; Maurer, Katie; Park, Cameron Y.; Choo, Zi-Ning; Li, Shuqiang; Gohil, Satyen H.; Ruthen, Neil G.; Ge, Zhongqi; Keskin, Derin B.; Cieri, Nicoletta; Livak, Kenneth J.; Kim, Haesook T.; Neuberg, Donna S.; Soiffer, Robert J.; Ritz, Jerome; Alyea, Edwin P.; Pe’er, Dana; Wu, Catherine J.

In Cell Reports 29 August 2023 42(8)

Antony, Sumy; Aitken, Jade; Vogt, Stefan; Lai, Barry; Brown, Tracey; Spiccia, Leone; Harris, Hugh

Journal of Biological Inorganic Chemistry (JBIC). Oct2013, Vol. 18 Issue 7, p845-853. 9p.

Iorgulescu JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Ruthen N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Ahn R; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.; Panagioti E; Department of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, United States.; Neagu M; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.; Speranza MC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Eschle BK; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, United States.; Soroko KM; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, United States.; Piranlioglu R; Department of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Datta M; Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.; Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN, United States.; Krishnan S; Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.; Yates KB; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, United States.; Baker GJ; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA, United States.; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, United States.; Jain RK; Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.; Suvà ML; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, United States.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.; Neuberg D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; White FM; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.; Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Sharpe AH; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Reardon DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.; Guièze R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; CHU de Clermont-Ferrand, Clermont-Ferrand, France.; Université Clermont Auvergne, EA7453 CHELTER, Clermont-Ferrand, France.; Johnson C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Tausch E; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Lemvigh C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Broséus J; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Université de Lorraine, CHRU-Nancy, service d'hématologie biologique, pôle laboratoires, Nancy, France.; Hergalant S; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Messer C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Utro F; IBM Research, Yorktown Heights, New York, NY, USA.; Levovitz C; IBM Research, Yorktown Heights, New York, NY, USA.; Rhrissorrakrai K; IBM Research, Yorktown Heights, New York, NY, USA.; Li L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Rosebrock D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Deng S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Slowik K; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Jacobs R; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Huang T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Fell G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Redd R; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Lin Z; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Knisbacher BA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Livitz D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Schneider C; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Ruthen N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Elagina L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Taylor-Weiner A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Persaud B; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Martinez A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Purroy N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Anandappa AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Ma J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Hess J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Rassenti LZ; Moores Cancer Center, Medicine, University of California, San Diego, La Jolla, CA, USA.; Kipps TJ; Moores Cancer Center, Medicine, University of California, San Diego, La Jolla, CA, USA.; Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cymbalista F; Laboratoire d'hématologie, Hôpital Avicenne-AP-HP, INSERM U978- Université Sorbonne Paris Nord, Bobigny, France.; Feugier P; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Université de Lorraine, CHRU Nancy, service d'hématologie clinique, Nancy, France.; Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Danysh BP; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Stewart C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Parida L; IBM Research, Yorktown Heights, New York, NY, USA.; Stilgenbauer S; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cwu@partners.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. cwu@partners.org.; Harvard Medical School, Boston, MA, USA. cwu@partners.org.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. cwu@partners.org.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE